Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences

ConclusionThe majority of individuals in this study had confidence in FF/VI and were satisfied or very satisfied with various key attributes of the treatment.Trial RegistrationGSK study HO-15-15503/204888.FundingGSK.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research